chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Incorrect route of product administration, Myalgia, Swelling, Tenderness
Clinical narrative: Patient requested to received vaccine in the "left gluteal area". Spoke to patient via telephone and she states "I would rather it there than anywhere else. I highly recommend it for women. I can actually move my arm." She report side affects " as to be expected" swollen, tender and muscle aches with chills" Patient states " I would not have gotten the vaccine if i could not get it there".
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pt was given Pfizer vaccine that had a BUD of 10/16/2021
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Respiratory arrest
Clinical narrative: patient administered vaccine. abruptly passed out and appears to have stopped breathing. epi administered and patient regained consciousness,
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Vertigo
Clinical narrative: 6 days after booster woke with extreme vertigo which improved with decrease movement.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Oxygen saturation decreased, Pleural effusion
Clinical narrative: low 02 sats, needing more 02 to keep her sats up
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anaemia, Blood creatinine increased, Blood glucose increased
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood magnesium, Blood potassium increased, Blood sodium decreased, Blood urea increased, COVID-19
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Cardiac failure congestive, Cellulitis, Chest X-ray abnormal, Cough
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dizziness, Dyspnoea, Dyspnoea exertional, Endotracheal intubation
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Gastrostomy, Haemoglobin decreased, Headache, Hyperglycaemia, Hyperkalaemia
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyponatraemia, Hypotension, Limb injury, Malaise, Mechanical ventilation
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Nausea, Oral candidiasis, Pain, Polyuria
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Tachycardia, Tracheostomy, Transaminases increased
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ventricular extrasystoles, Vomiting
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anaemia, Blood creatinine, Blood creatinine increased
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood glucose, Blood glucose increased, Blood magnesium, Blood potassium, Blood potassium increased
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Blood sodium, Blood sodium decreased, Blood urea, Blood urea increased
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, COVID-19, COVID-19 pneumonia, Cardiac failure congestive, Cellulitis
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Chest X-ray abnormal, Cough, Diarrhoea, Dizziness
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Endotracheal intubation, Gastrostomy, Haemoglobin
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin decreased, Headache, Heart rate, Hyperglycaemia, Hyperkalaemia
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive, Tachycardia, Tracheostomy
Clinical narrative: J&J Dose 6/2/21 (lot not listed in database) COVID Positive 8/29/21  8/29/21: Pt is a 51 year old male who presented to ED with a chief complaint of vomiting. He has a past medical history of BPH, hypertension, type 2 diabetes mellitus, and GERD. Pt started feeling unwell on Tuesday of last week. He had fever, dizziness, body aches, headache and vomiting. He has had persistent vomiting since Tuesday. He has chronic bilateral lower extremities wounds, he is being seen by wound care. He was seen by urgent care with concerns for cellulitis and placed on cipro. He symptoms have worsened and he has developed severe shortness of breath, worse on exertion, and a dry cough. He has developed some nausea with diarrhea. He does wear a BIPAP at home. He is not on any diuretics. He believes he might have been told in the past he has congestive heart failure but is unsure. He has been full Covid-19 vaccinated.  On arrival to ED patient was febrile 101.3, tachycardic 113 hypotensive 99/66.  Laboratory findings were significant for hyponatremia 126. Hyperkalemia 5.4. Hyperglycemia 422. AKI BUN 27 and creatinine 2.84. Transaminitis 51. Anemia HGB 11.3. Chest x-ray showed CHF, superimposed pneumonia is not excluded. IV Levaquin was initiated in ED.  IV hydration NS 0.9% 1 L bolus given in ED.  9/22/21: Pt is a 51-year-old male with PMHx significant for HTN, T2DM, GERD, BPH and morbid obesity who was admitted on 8/29/2021 for acute hypoxic respiratory failure due to COVID PNA.  Patient was intubated on 08/30/2021.  He is s/p remdesivir, Actemra, dexamethasone, Rocephin, azithromycin, ceftazidime, vancomycin and Zosyn. He was diuresed with Lasix.  He remained on mechanical ventilation throughout hospitalization.  Patient was removed from precautions on 09/17/2021 and tracheostomy and PEG tube were placed at that time.  He was weaned from his paralytic on 09/18/2021.  He continues on Lovenox 40 mg subQ daily for VTE prophylaxis.  Patient with multifocal ventricular ectopy while hospitalized.  Cardiology was consulted.  Suspected etiology 2/2 COVID myocarditis. Patient unable to tolerate beta-blockers.  Magnesium levels and potassium levels were optimized.  Patient continues on tube feeds via PEG tube.  He has history of T2DM and was on GlucoStabilizer protocol but eventually transitioned to Lantus 35U BID with correctional dose insulin.  Patient with oral candidal lesions on 09/22/2021.  Started on nystatin oral solution 4 times daily for 7 days.  Patient was accepted by (privacy) and discharged to local HCF.